Home Cart Sign in  
Chemical Structure| 1032229-33-6 Chemical Structure| 1032229-33-6

Structure of A939572
CAS No.: 1032229-33-6

Chemical Structure| 1032229-33-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

A939572 is a potent and orally active inhibitor of stearoyl-CoA desaturase 1 (SCD1), targeting mSCD1 and hSCD1 with IC50 values of <4 nM and 37 nM, respectively.

Synonyms: SCD1 Inhibitor; Stearoyl-CoA Desaturase 1 Inhibitor

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of A939572

CAS No. :1032229-33-6
Formula : C20H22ClN3O3
M.W : 387.86
SMILES Code : O=C(N1CCC(OC2=CC=CC=C2Cl)CC1)NC3=CC=CC(C(NC)=O)=C3
Synonyms :
SCD1 Inhibitor; Stearoyl-CoA Desaturase 1 Inhibitor
MDL No. :MFCD10698997
InChI Key :DPYTYQFYDLYWHZ-UHFFFAOYSA-N
Pubchem ID :24905400

Safety of A939572

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of A939572

ferroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Bladder cancer cell lines 0, 3.2 and 25.6 µg/mL 24 h reduce cell proliferation PMC6378218
Caki1 cells 65 nM 5 days A939572 significantly inhibited the proliferation of Caki1 cells, induced apoptosis, and this effect could be reversed by the addition of OA-BSA. PMC3644999
A498 cells 50 nM 5 days A939572 significantly inhibited the proliferation of A498 cells, induced apoptosis, and this effect could be reversed by the addition of OA-BSA. PMC3644999
Caki2 cells 65 nM 5 days A939572 significantly inhibited the proliferation of Caki2 cells, induced apoptosis, and this effect could be reversed by the addition of OA-BSA. PMC3644999
ACHN cells 6 nM 5 days A939572 significantly inhibited the proliferation of ACHN cells, induced apoptosis, and this effect could be reversed by the addition of OA-BSA. PMC3644999

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice HFD-fed mice Intraperitoneal injection 5 mg/kg/d 12 weeks The treatment improved insulin sensitivity and normalized plasma insulin levels. PMC3839776
Athymic nude (nu/nu) mice A498 ccRCC xenograft model Oral 30mg/kg twice daily for 4 weeks A939572 monotherapy significantly inhibited tumor growth, and combination with Temsirolimus showed synergistic antitumor effects. PMC3644999

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.89mL

2.58mL

1.29mL

25.78mL

5.16mL

2.58mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories